Penicillin 20 % (n = 13) | Aminopenicillins 38 % (n = 24) | Cephalosporins 42 % (n = 27) | Total 100 %(n = 64) | |
---|---|---|---|---|
positive in vivo results and negative BAT | 23 % (n = 3) | 17 % (n = 4) | – | 11 % (n = 7) |
negative in vivo results as well as absence of specific IgE and positive BAT | 15 % (n = 2) | 17 % (n = 4) | 22 % (n = 6) | 19 % (n = 12) |
positive in vivo results and positive BAT | – | 8 % (n = 2) | 4 % (n = 1) | 4.5 % (n = 3) |
positive in vivo results, positive specific IgE and negative BAT | – | 4 % (n = 1) | – | 1.5 % (n = 1) |
negative in vivo results and negative BAT | 62 % (n = 8) | 54 % (n = 13) | 74 % (n = 20) | 64 % (n = 41) |